20:30:54 EDT Sat 05 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

V:NGEN - Nervgen Pharma Corp. - https://www.nervgen.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NGEN - V  1.23.55·3.603.03.55+0.061.764.72241833.47  3.85  3.317.05  2.0515:59:53Jul 0315 min RT 2¢
TSX-V - V1.23.55·3.603.03.55+0.061.744.1154743.47  3.85  3.317.05  2.0515:59:5315 min
NEO ATS - U 3.55+0.061.77.125173.49  3.80  3.3815:47:1615 min
Alpha - A 3.64+0.154.33.712103.32  3.64  3.3215:30:0215 min
Omega - O 3.70+0.216.03.31263.48  3.70  3.4815:28:4915 min
Pure - P 3.490.012    Jun 2715 min
CX2 - H 3.57+0.082.31.1423.60  3.60  3.5715:28:4915 min
CXD - D 3.64+0.154.31.64443.42  3.67  3.4215:29:1215 min
TriAct - M 3.492.7826    Sep 04/2015 min
Lynx - Y 3.69+0.205.71.1423.50  3.69  3.5015:26:0615 min

Recent Trades - Last 10 of 183
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59U3.600.119679 CIBC7 TD SecE
15:59:59U3.600.119679 CIBC7 TD SecE
15:59:53V3.550.0650062 Haywood1 AnonymousK
15:59:29V3.580.0910080 National Bank79 CIBCK
15:59:29P3.590.10139 Merrill Lynch7 TD SecE
15:59:29V3.580.091001 Anonymous79 CIBCK
15:50:27D3.600.115124 Questrade2 RBCE
15:47:16U3.550.061002 RBC124 QuestradeK
15:47:16U3.550.061002 RBC124 QuestradeK
15:47:16M3.550.067714 Virtu ITG124 QuestradeE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-03 19:55C:NGEN3.49News ReleaseNervgen Pharma director Ives resigns
2025-07-01 07:31C:NGEN3.44News ReleaseNervGen Announces Clinical Leadership Transition as NVG-291 Continues to Advance Toward Late-Stage Development and Regulatory Milestones
2025-06-18 16:40C:NGEN3.58News ReleaseNervgen appoints Kaye as chief medical adviser
2025-06-02 16:48C:NGEN3.55News ReleaseNervgen finds NVG-291 meets only 1 co-primary end point
2025-06-02 10:22C:NGEN5.15Resume TradingNervgen Pharma to resume at 7:24 a.m. PT
2025-06-02 10:21C:NGEN5.15Halt TradingNervgen Pharma halted at 7:19 a.m. PT
2025-06-02 10:18C:NGEN5.15Resume TradingNervgen Pharma resumes at 7:15 a.m. PT
2025-06-02 10:17C:NGEN5.15Halt TradingNervgen Pharma halted at 7:10 a.m. PT
2025-06-02 09:55C:NGEN5.15News ReleaseCanadian Investment Regulatory Organization Trade Resumption - NGEN
2025-06-02 09:52C:NGEN5.15News ReleaseCanadian Investment Regulatory Organization Trading Halt - NGEN
2025-06-02 09:40C:NGEN5.15Resume TradingNervgen Pharma to resume at 6:43 a.m. PT
2025-06-02 09:39C:NGEN5.15Halt TradingNervgen Pharma halted at 6:38 a.m. PT
2025-05-23 10:32C:NGEN5.40News ReleaseCanadian Investment Regulatory Organization Trade Resumption - NGEN
2025-05-23 10:28C:NGEN5.40News ReleaseCanadian Investment Regulatory Organization Trading Halt - NGEN
2025-05-23 10:16C:NGEN5.40Resume TradingNervgen Pharma to resume at 7:18 a.m. PT
2025-05-23 10:15C:NGEN5.40Halt TradingNervgen Pharma halted at 7:13 a.m. PT
2025-05-21 22:37C:NGEN6.57News ReleaseNervgen Pharma to present NVG-291 study data
2025-05-16 18:33C:NGEN4.68News ReleaseNervgen Pharma grants options to buy 600,000 shares
2025-05-15 07:31C:NGEN3.60News ReleaseNervGen Pharma Reports Q1 2025 Financial Results and Provides Operational Updates
2025-05-15 07:10C:NGEN3.60SEDAR Interim Financial StatementsSEDAR Interim Financial Statements